AI-based method predicts small molecule substrates of enzymes

Enzymes are the molecule factories in biological cells. However, which basic molecular building blocks they use to assemble target molecules is often unknown and difficult to measure. An international team including bioinformaticians from Heinrich Heine University Düsseldorf (HHU) has now taken an important step forward in this regard: Their AI method predicts with a high degree of accuracy whether an enzyme can work with a specific substrate. They now present their results in the scientific journal Nature Communications.

Enzymes are important biocatalysts in all living cells: They facilitate chemical reactions, through which all molecules important for the organism are produced from basic substances (substrates). Most organisms possess thousands of different enzymes, with each one responsible for a very specific reaction. The collective function of all enzymes makes up the metabolism and thus provides the conditions for the life and survival of the organism.

Even though genes which encode enzymes can easily be identified as such, the exact function of the resultant enzyme is unknown in the vast majority – over 99% – of cases. This is because experimental characterisations of their function – i.e. which starting molecules a specific enzyme converts into which concrete end molecules – is extremely time-consuming.

Together with colleagues from Sweden and India, the research team headed by Professor Dr Martin Lercher from the Computational Cell Biology research group at HHU has developed an AI-based method for predicting whether an enzyme can use a specific molecule as a substrate for the reaction it catalyses.

The special feature of our ESP ("Enzyme Substrate Prediction") model is that we are not limited to individual, special enzymes and others closely related to them, as was the case with previous models. Our general model can work with any combination of an enzyme and more than 1,000 different substrates."

Professor Dr Martin Lercher from the Computational Cell Biology research group at HHU

PhD student Alexander Kroll, lead author of the study, has developed a so-called Deep Learning model in which information about enzymes and substrates was encoded in mathematical structures known as numerical vectors. The vectors of around 18,000 experimentally validated enzyme-substrate pairs – where the enzyme and substrate are known to work together – were used as input to train the Deep Learning model.

Alexander Kroll: "After training the model in this way, we then applied it to an independent test dataset where we already knew the correct answers. In 91% of cases, the model correctly predicted which substrates match which enzymes."

This method offers a wide range of potential applications. In both drug research and biotechnology it is of great importance to know which substances can be converted by enzymes. Professor Lercher: "This will enable research and industry to narrow a large number of possible pairs down to the most promising, which they can then use for the enzymatic production of new drugs, chemicals or even biofuels."

Kroll adds: "It will also enable the creation of improved models to simulate the metabolism of cells. In addition, it will help us understand the physiology of various organisms – from bacteria to people."

Alongside Kroll and Lercher, Professor Dr Martin Engqvist from the Chalmers University of Technology in Gothenburg, Sweden, and Sahasra Ranjan from the Indian Institute of Technology in Mumbai were also involved in the study. Engqvist helped design the study, while Ranjan implemented the model which encodes the enzyme information fed into the overall model developed by Kroll.

Source:
Journal reference:

Kroll, A., et al. (2023). A general model to predict small molecule substrates of enzymes based on machine and deep learning. Nature Communications. doi.org/10.1038/s41467-023-38347-2.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Small brain-penetrating molecule offers hope for treating aggressive brain tumors